Prophylactic urethral stenting with Memokath(®) 028SW in prostate cancer patients undergoing prostate (125)I seed implants: phase I/II study

PURPOSE: To study the feasibility/toxicity of urethral stenting with the Memokath(®) 028SW stent in patients undergoing prostate implant (PI) for prostate adenocarcinoma. MATERIAL AND METHODS: An Investigational Device Exemption from the Food and Drug Administration (FDA) and institutional review bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Samuel T., Angermeier, Kenneth, Klein, Eric A., Reddy, Chandana A., Ulchaker, James C., Stephenson, Andrew, Campbell, Steven, Ciezki, Jay P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108832/
https://www.ncbi.nlm.nih.gov/pubmed/27877196
http://dx.doi.org/10.5114/jcb.2011.21038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108832/
https://www.ncbi.nlm.nih.gov/pubmed/27877196
http://dx.doi.org/10.5114/jcb.2011.21038

Ejemplares similares